Through the American Recovery and Reinvestment Act of 2009, the US federal government has allocated $1.1 billion for research into the comparative effectiveness of different medical treatments. New reports just out prioritize atrial fibrillation treatment on this comparative effectiveness research agenda.
Comparative effectiveness research has the potential to improve atrial fibrillation patient treatment and save health care costs.
Two reports just released by the Federal Coordinating Council for Comparative Effectiveness Research and the Institute of Medicine outline the comparative effectiveness research priorities.
To learn more, read: Comparative Effectiveness Research for Atrial Fibrillation Treatment Is Listed as High Priority